{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:33:52Z","timestamp":1791005632049,"version":"4.1.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.molmed.2024.06.005","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T22:29:13Z","timestamp":1719872953000},"page":"1076-1089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cognitive impairment in people living with HIV: mechanisms, controversies, and future perspectives"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9954-7409","authenticated-orcid":false,"given":"Charalampos D.","family":"Moschopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Alford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Antoniadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime H.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.06.005_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00281-022-00953-5","article-title":"Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection","volume":"44","author":"Killingsworth","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101792","article-title":"Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not","volume":"56","author":"Aung","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.molmed.2024.06.005_bb0015","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1093\/cid\/ciac658","article-title":"Declining prevalence of human immunodeficiency virus (HIV)-associated neurocognitive disorders in recent years and associated factors in a large cohort of antiretroviral therapy-treated individuals with HIV","volume":"76","author":"Mastrorosa","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0020","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/hiv.13472","article-title":"One for all, all for one: neuro\u2010HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV","volume":"24","author":"Damas","year":"2023","journal-title":"HIV Med."},{"key":"10.1016\/j.molmed.2024.06.005_bb0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41582-023-00813-2","article-title":"Cognitive impairment in people living with HIV: consensus recommendations for a new approach","volume":"19","author":"Nightingale","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41582-024-00927-1","article-title":"Cognitive criteria in HIV: greater consensus is needed","volume":"20","author":"Cysique","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw5589","article-title":"The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation","volume":"11","author":"Abrahams","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2024.06.005_bb0040","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/cells8101245","article-title":"New challenges of HIV-1 infection: how HIV-1 attacks and resides in the central nervous system","volume":"8","author":"Rojas-Celis","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.molmed.2024.06.005_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2534","article-title":"Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous system","volume":"34","author":"Calado","year":"2024","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0050","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/infdis\/jiac370","article-title":"Biotypes of central nervous system complications in people with human immunodeficiency virus: virology, immunology, and neuropathology","volume":"227","author":"Joseph","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.20411\/pai.v7i2.524","article-title":"HIV-1 is transported into the central nervous system by trafficking infected cells","volume":"7","author":"Kincer","year":"2023","journal-title":"Pathog. Immun."},{"key":"10.1016\/j.molmed.2024.06.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010105","article-title":"Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection","volume":"17","author":"Sharma","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.06.005_bb0065","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI127413","article-title":"Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance","volume":"129","author":"Spudich","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2024.06.005_bb0070","first-page":"260","article-title":"Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus","volume":"8","author":"Kincer","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11481-018-9809-2","article-title":"Macrophages but not astrocytes harbor HIV DNA in the brains of HIV-1-infected aviremic individuals on suppressive antiretroviral therapy","volume":"14","author":"Ko","year":"2019","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0080","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.26456","article-title":"Intact HIV proviruses persist in the brain despite viral suppression with ART","volume":"92","author":"Cochrane","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11904-022-00605-1","article-title":"HIV Compartmentalization in the CNS and its impact in treatment outcomes and cure strategies","volume":"19","author":"Chan","year":"2022","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.molmed.2024.06.005_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2023.1291996","article-title":"Evolution driven by a varying host environment selects for distinct HIV-1 entry phenotypes and other informative variants","volume":"3","author":"Zhou","year":"2023","journal-title":"Front. Virol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/JLB.2RI0517-200R","article-title":"The evolution of HIV-1 entry phenotypes as a guide to changing target cells","volume":"103","author":"Joseph","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0100","doi-asserted-by":"crossref","first-page":"15866","DOI":"10.1038\/s41598-020-71699-z","article-title":"Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection","volume":"10","author":"Connell","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2024.06.005_bb0105","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.3390\/v3112255","article-title":"Viral determinants of HIV-1 macrophage tropism","volume":"3","author":"Duncan","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.molmed.2024.06.005_bb0110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41582-023-00879-y","article-title":"Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management","volume":"19","author":"Ellis","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0115","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1128\/JVI.00946-15","article-title":"Phenotypic correlates of HIV-1 macrophage tropism","volume":"89","author":"Arrildt","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004720","article-title":"Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection","volume":"11","author":"Sturdevant","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.06.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010335","article-title":"HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages","volume":"18","author":"Han","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.06.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002286","article-title":"HIV-1 replication in the central nervous system occurs in two distinct cell types","volume":"7","author":"Schnell","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.06.005_bb0135","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1097\/QAD.0000000000002253","article-title":"What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?","volume":"33","author":"Joseph","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250987","article-title":"Compartmentalization of cerebrospinal fluid inflammation across the spectrum of\u202funtreated HIV-1 infection, central nervous system injury and viral suppression","volume":"16","author":"Gisslen","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2024.06.005_bb0145","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3390\/cells8080902","article-title":"Deep sequencing reveals central nervous system compartmentalization in multiple transmitted\/founder virus acute HIV-1 infection","volume":"8","author":"Tovanabutra","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.molmed.2024.06.005_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/QCO.0000000000000825","article-title":"Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis","volume":"35","author":"Johnson","year":"2022","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-444-63849-6.00007-4","article-title":"HIV-associated neurocognitive disorder","volume":"152","author":"Smail","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0160","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s12035-019-01795-3","article-title":"White matter abnormalities linked to interferon, stress response, and energy metabolism gene expression changes in older HIV-positive patients on antiretroviral therapy","volume":"57","author":"Solomon","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0165","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/WCO.0000000000000807","article-title":"Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies","volume":"33","author":"McArthur","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0170","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11904-021-00548-z","article-title":"Neuroimaging the neuropathogenesis of HIV","volume":"18","author":"Boerwinkle","year":"2021","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.molmed.2024.06.005_bb0175","doi-asserted-by":"crossref","first-page":"e1085","DOI":"10.1212\/WNL.0000000000012394","article-title":"Alterations of brain metabolites in adults with HIV","volume":"97","author":"Dahmani","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2024.06.005_bb0180","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001144","article-title":"Multimodal investigation of neuroinflammation in aviremic patients with HIV on antiretroviral therapy and HIV elite controllers","volume":"9","author":"Sari","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.molmed.2024.06.005_bb0185","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/QAD.0000000000002268","article-title":"Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy","volume":"33","author":"Henderson","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0190","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210584119","article-title":"Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury","volume":"119","author":"Suzuki","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.06.005_bb0195","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1016\/S2352-3018(20)30107-7","article-title":"Cognitive disorders in people living with HIV","volume":"7","author":"Winston","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.molmed.2024.06.005_bb0200","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/hiv.12714","article-title":"Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV\u2010negative controls","volume":"20","author":"De Francesco","year":"2019","journal-title":"HIV Med."},{"key":"10.1016\/j.molmed.2024.06.005_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194760","article-title":"Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment","volume":"13","author":"Underwood","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2024.06.005_bb0210","first-page":"238","article-title":"Antiretroviral therapy improves neurocognitive impairment in people living with HIV? A meta-analysis","volume":"7","author":"Gao","year":"2020","journal-title":"Int. J. Nurs. Sci."},{"key":"10.1016\/j.molmed.2024.06.005_bb0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-12-39","article-title":"Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study","volume":"12","author":"Joska","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0220","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/QAD.0000000000001778","article-title":"No neurocognitive advantage for immediate antiretroviral treatment in adults with\u202fgreater than 500 CD4+ T-cell counts","volume":"32","author":"Wright","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0225","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","article-title":"Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy","volume":"73","author":"Cysique","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2024.06.005_bb0230","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1212\/WNL.0000000000200829","article-title":"Longitudinal effects of combination antiretroviral therapy on cognition and neuroimaging biomarkers in treatment-naive people with HIV","volume":"99","author":"Weber","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2024.06.005_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006112","article-title":"Early antiretroviral therapy is associated with lower HIV DNA molecular diversity and lower inflammation in cerebrospinal fluid but does not prevent the establishment of compartmentalized HIV DNA populations","volume":"13","author":"Oliveira","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.06.005_bb0240","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11481-019-09886-7","article-title":"CNS neurotoxicity of antiretrovirals","volume":"16","author":"Lanman","year":"2021","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0245","doi-asserted-by":"crossref","first-page":"12242","DOI":"10.3390\/ijms241512242","article-title":"Contemporary antiretroviral therapy dysregulates iron transport and augments mitochondrial dysfunction in HIV-infected human microglia and neural-lineage cells","volume":"24","author":"Kaur","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2024.06.005_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104502","article-title":"Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia","volume":"130","author":"Swinton","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0255","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1093\/cid\/ciaa984","article-title":"Mitochondrial DNA damage and brain aging in human immunodeficiency virus","volume":"73","author":"Roca-Bayerri","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0260","article-title":"Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-na\u00efve individuals","volume":"2016","author":"Mbuagbaw","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.molmed.2024.06.005_bb0265","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1097\/QAI.0000000000001876","article-title":"Objective and subjective improvement of cognition after discontinuing efavirenz in asymptomatic patients: a randomized controlled trial","volume":"80","author":"Hakkers","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.molmed.2024.06.005_bb0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/brainsci9080195","article-title":"Improved central nervous system symptoms in people with HIV without objective neuropsychiatric complaints switching from efavirenz to rilpivirine containing cART","volume":"9","author":"Vera","year":"2019","journal-title":"Brain Sci."},{"key":"10.1016\/j.molmed.2024.06.005_bb0275","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s13365-020-00870-z","article-title":"Lifetime antiretroviral exposure and neurocognitive impairment in HIV","volume":"26","author":"Amusan","year":"2020","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0280","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/QAD.0000000000002236","article-title":"Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors","volume":"33","author":"O\u2019Halloran","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639378","article-title":"Physiologically relevant concentrations of dolutegravir, emtricitabine, and efavirenz induce distinct metabolic alterations in HeLa epithelial and BV2 microglial cells","volume":"12","author":"George","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0290","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11481-019-09858-x","article-title":"Cerebral vascular toxicity of antiretroviral therapy","volume":"16","author":"Bertrand","year":"2021","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0295","doi-asserted-by":"crossref","first-page":"e2466","DOI":"10.1212\/WNL.0000000000207339","article-title":"Neurocognitive dysfunction with neuronal injury in people with HIV on long-duration antiretroviral therapy","volume":"100","author":"McMahan","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2024.06.005_bb0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/QAD.0000000000003071","article-title":"Legacy effect on neuropsychological function in HIV-infected men on combination antiretroviral therapy","volume":"36","author":"Qu","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0305","first-page":"423","article-title":"Neurocognition and the aging brain in people with HIV: implications for screening","volume":"29","author":"Chan","year":"2022","journal-title":"Top Antivir. Med."},{"key":"10.1016\/j.molmed.2024.06.005_bb0310","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cjtee.2018.02.003","article-title":"Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities","volume":"21","author":"Xiong","year":"2018","journal-title":"Chin. J. Traumatol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0315","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145928","article-title":"Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells","volume":"6","author":"van der Heijden","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmed.2024.06.005_bb0320","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/v15091835","article-title":"Increasing neuroinflammation relates to increasing neurodegeneration in people with HIV","volume":"15","author":"Tavasoli","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.molmed.2024.06.005_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.106994","article-title":"HIV-1 Tat is present in the serum of people living with HIV-1 despite viral suppression","volume":"142","author":"Shmakova","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0330","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/QAD.0000000000001858","article-title":"Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy","volume":"32","author":"Rubin","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0335","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.0000000000002485","article-title":"Neuroinflammation in treated HIV-positive individuals","volume":"86","author":"Vera","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2024.06.005_bb0340","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/cid\/ciac870","article-title":"Impact of human immunodeficiency virus and recreational drugs on cognitive functions","volume":"76","author":"Henrard","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0345","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/QAD.0000000000002980","article-title":"Increased immune activation and signs of neuronal injury in HIV-negative people on preexposure prophylaxis","volume":"35","author":"Robertson","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0350","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/QAD.0000000000002597","article-title":"HIV and risk of dementia in older veterans","volume":"34","author":"Bobrow","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0355","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/brain\/awac465","article-title":"Twelve-year neurocognitive decline in HIV is associated with comorbidities, not\u202fage: a CHARTER study","volume":"146","author":"Heaton","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2024.06.005_bb0360","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/cid\/ciz670","article-title":"Increased prevalence of neurocognitive impairment in aging people living with human immunodeficiency virus: the ANRS EP58 HAND 55\u201370 study","volume":"70","author":"Makinson","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0365","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/7854_2019_119","article-title":"Geriatric syndromes in people living with HIV associated with ageing and increasing comorbidities: implications for neurocognitive complications of HIV infection","volume":"50","author":"Falutz","year":"2019","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.molmed.2024.06.005_bb0370","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s11357-023-00759-9","article-title":"Accelerated epigenetic aging in older adults with HIV disease: associations with serostatus, HIV clinical factors, and health literacy","volume":"45","author":"Woods","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.molmed.2024.06.005_bb0375","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/cid\/ciab563","article-title":"Epigenetic aging biomarkers associated with cognitive impairment in older African American adults with human immunodeficiency virus (HIV)","volume":"73","author":"Shiau","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0380","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12877-022-03719-8","article-title":"Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV","volume":"23","author":"Bra\u00f1as","year":"2023","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.molmed.2024.06.005_bb0385","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/jgs.17569","article-title":"Polypharmacy in older adults with HIV infection: effects on the brain","volume":"70","author":"Smith","year":"2022","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.molmed.2024.06.005_bb0390","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3851\/IMP3293","article-title":"Polypharmacy and drug\u2013drug interactions in older and younger people living with HIV: The POPPY Study","volume":"24","author":"Halloran","year":"2019","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.molmed.2024.06.005_bb0395","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/hiv.13082","article-title":"The shifting picture of HIV treatment, comorbidity and substance use among US MSM living with HIV","volume":"22","author":"D\u2019Souza","year":"2021","journal-title":"HIV Med."},{"key":"10.1016\/j.molmed.2024.06.005_bb0400","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11481-020-09941-8","article-title":"Opioid and neuroHIV comorbidity \u2013 current and future perspectives","volume":"15","author":"Fitting","year":"2020","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0405","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/sextrans-2019-054040","article-title":"Chemsex-related drug use and its association with health outcomes in men who have sex with men: a cross-sectional analysis of Antidote clinic service data","volume":"96","author":"Stevens","year":"2020","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.molmed.2024.06.005_bb0410","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/v15030674","article-title":"The combined effects of cannabis, methamphetamine, and HIV on neurocognition","volume":"15","author":"Rogers","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.molmed.2024.06.005_bb0415","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/WNL.0000000000001156","article-title":"Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected\u202fpeople","volume":"84","author":"Clifford","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2024.06.005_bb0420","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/QAD.0000000000003420","article-title":"The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum","volume":"37","author":"Lang","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0425","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/ijerph16111899","article-title":"Understanding global HIV stigma and discrimination: are contextual factors sufficiently studied? (GAPRESEARCH)","volume":"16","author":"Tran","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.molmed.2024.06.005_bb0430","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.3390\/ijerph20043687","article-title":"Determinants of depressive symptoms in people living with HIV: findings from a population-based study with a gender perspective","volume":"20","author":"Bayes-Marin","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.molmed.2024.06.005_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1130938","article-title":"The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment","volume":"17","author":"Goodkin","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.molmed.2024.06.005_bb0440","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/cells10082158","article-title":"HIV-associated apathy\/depression and neurocognitive impairments reflect persistent dopamine deficits","volume":"10","author":"McLaurin","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.molmed.2024.06.005_bb0445","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41398-023-02489-0","article-title":"Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms","volume":"13","author":"Mudra Rakshasa-Loots","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.molmed.2024.06.005_bb0450","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/QAI.0000000000002346","article-title":"Cumulative burden of depression and neurocognitive decline among persons with HIV: a longitudinal study","volume":"84","author":"Paolillo","year":"2020","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.molmed.2024.06.005_bb0455","series-title":"HIV Psychiatry","first-page":"181","article-title":"HIV-Associated Neurocognitive Disorders and Delirium","author":"Hirsch","year":"2022"},{"key":"10.1016\/j.molmed.2024.06.005_bb0460","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/jgs.18265","article-title":"Delirium among people aging with and without HIV: Role of alcohol and Neurocognitively active medications","volume":"71","author":"Akg\u00fcn","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.molmed.2024.06.005_bb0465","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2024.06.005_bb0470","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/QAD.0000000000003379","article-title":"The global burden of cognitive impairment in people with HIV","volume":"37","author":"Keng","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0475","doi-asserted-by":"crossref","first-page":"e2610","DOI":"10.1212\/WNL.0000000000010752","article-title":"Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis","volume":"95","author":"Wang","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2024.06.005_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.814362","article-title":"Worldwide occurrence of HIV-associated neurocognitive disorders and its associated factors: a systematic review and meta-analysis","volume":"13","author":"Zenebe","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.molmed.2024.06.005_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.581346","article-title":"The prevalence of Frascati-criteria-based HIV-associated neurocognitive disorder (HAND) in HIV-infected adults: a systematic review and meta-analysis","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0490","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/QAD.0000000000002709","article-title":"Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a\u202f3-year study period","volume":"35","author":"Rourke","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0495","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/cid\/ciab366","article-title":"Moving on from HAND: why we need new criteria for cognitive impairment in persons living with human immunodeficiency virus and a proposed way forward","volume":"73","author":"Nightingale","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0500","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1097\/QAD.0000000000003057","article-title":"Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV","volume":"35","author":"Damas","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0505","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27584","article-title":"Aging-related comorbidity burden among women and men with or at-risk for HIV in the US, 2008-2019","volume":"6","author":"Collins","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.molmed.2024.06.005_bb0510","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cid\/ciab682","article-title":"Strengths and challenges of various models of geriatric consultation for older adults living with human immunodeficiency virus","volume":"74","author":"Davis","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0515","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40520-019-01183-w","article-title":"Comprehensive geriatric assessment in primary care: a systematic review","volume":"32","author":"Garrard","year":"2020","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.molmed.2024.06.005_bb0520","series-title":"Neurocognitive Complications of HIV-Infection","first-page":"517","article-title":"Clinical treatment options and randomized clinical trials for neurocognitive complications of HIV infection: combination antiretroviral therapy, central nervous system penetration effectiveness, and adjuvants","author":"Lin","year":"2020"},{"key":"10.1016\/j.molmed.2024.06.005_bb0525","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s11904-022-00612-2","article-title":"Developments in neuroprotection for HIV-associated neurocognitive disorders (HAND)","volume":"19","author":"Kolson","year":"2022","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.molmed.2024.06.005_bb0530","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/cid\/ciad265","article-title":"Antiretroviral therapy intensification for neurocognitive impairment in human immunodeficiency virus","volume":"77","author":"Letendre","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0535","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11904-020-00515-0","article-title":"Cognitive and neurologic rehabilitation strategies for central nervous system HIV infection","volume":"17","author":"Chan","year":"2020","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.molmed.2024.06.005_bb0540","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1007\/s11136-022-03150-x","article-title":"\u2018A fog that impacts everything\u2019: a qualitative study of health-related quality of life in people living with HIV who have cognitive impairment","volume":"31","author":"Alford","year":"2022","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.molmed.2024.06.005_bb0545","doi-asserted-by":"crossref","DOI":"10.1177\/23259582231164241","article-title":"Health-related quality of life in people living with HIV with cognitive symptoms: assessing relevant domains and associations","volume":"22","author":"Alford","year":"2023","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"key":"10.1016\/j.molmed.2024.06.005_bb0550","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/02692155221114587","article-title":"Aerobic exercise for HIV-associated neurocognitive disorders in individuals on antiretroviral therapy: a randomised controlled trial","volume":"36","author":"Nweke","year":"2022","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.molmed.2024.06.005_bb0555","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s13365-014-0240-z","article-title":"An active lifestyle is associated with better neurocognitive functioning in adults living with HIV infection","volume":"20","author":"Fazeli","year":"2014","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0560","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/01609513.2021.1963389","article-title":"Cognitive remediation group therapy compared to mutual aid group therapy for people aging with HIV-associated neurocognitive disorder: randomized, controlled trial","volume":"45","author":"Eaton","year":"2022","journal-title":"Soc. Work Groups"},{"key":"10.1016\/j.molmed.2024.06.005_bb0565","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/07853890.2020.1814962","article-title":"Important role of microglia in HIV-1 associated neurocognitive disorders and the\u202fmolecular pathways implicated in its pathogenesis","volume":"53","author":"Borrajo","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.molmed.2024.06.005_bb0570","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12981-023-00511-5","article-title":"Role of microglia in HIV-1 infection","volume":"20","author":"Bai","year":"2023","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.molmed.2024.06.005_bb0575","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1007\/s00018-020-03561-4","article-title":"Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND","volume":"77","author":"Marino","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2024.06.005_bb0580","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1267041","article-title":"HIV-associated neurotoxicity: the interplay of host and viral proteins","volume":"2021","author":"Jadhav","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.molmed.2024.06.005_bb0585","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fnagi.2020.00168","article-title":"Extracellular HIV-1 Tat mediates increased glutamate in the CNS leading to onset of senescence and progression of HAND","volume":"12","author":"Marino","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.molmed.2024.06.005_bb0590","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11904-010-0042-8","article-title":"HIV, antiretroviral therapies, and the brain","volume":"7","author":"Liner","year":"2010","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.molmed.2024.06.005_bb0595","article-title":"Cross-sectional and cumulative longitudinal central nervous system penetration effectiveness scores are not associated with neurocognitive impairment in a well treated aging human immunodeficiency virus-positive population in Switzerland","volume":"6","author":"Santos","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0600","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1080\/09540121.2022.2098231","article-title":"The effect of antiretroviral therapy with high central nervous system penetration on HIV-related cognitive impairment: a systematic review and meta-analysis","volume":"35","author":"Webb","year":"2023","journal-title":"AIDS Care"},{"key":"10.1016\/j.molmed.2024.06.005_bb0605","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hiv.13446","article-title":"BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022","volume":"23","author":"Waters","year":"2022","journal-title":"HIV Med."},{"key":"10.1016\/j.molmed.2024.06.005_bb0610","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/cis975","article-title":"Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program","volume":"56","author":"Mind Exchange Working Group","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0615","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/QAI.0000000000003189","article-title":"Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study","volume":"93","author":"Filippidis","year":"2023","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.molmed.2024.06.005_bb0620","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/hiv.13471","article-title":"Cerebrospinal fluid virology in people with HIV","volume":"24","author":"Henderson","year":"2023","journal-title":"HIV Med."},{"key":"10.1016\/j.molmed.2024.06.005_bb0625","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/QAD.0000000000002074","article-title":"Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects","volume":"33","author":"P\u00e9rez-Valero","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0630","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070693","article-title":"Cohort profile: a longitudinal study of HIV infection in the central nervous system with focus on cerebrospinal fluid \u2013 the Gothenburg HIV CSF Study Cohort","volume":"13","author":"Hagberg","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.molmed.2024.06.005_bb0635","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/cid\/ciab943","article-title":"Cerebrospinal fluid viral load across the spectrum of untreated human immunodeficiency virus type 1 (HIV-1) infection: a cross-sectional multicenter study","volume":"75","author":"Ulfhammer","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0640","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1097\/QAD.0000000000002266","article-title":"Symptomatic cerebrospinal fluid escape","volume":"33","author":"Mastrangelo","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.molmed.2024.06.005_bb0645","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/cid\/ciy1066","article-title":"Human immunodeficiency virus type 1 RNA detected in the central nervous system (CNS) after years of suppressive antiretroviral therapy can originate from a replicating CNS reservoir or clonally expanded cells","volume":"69","author":"Joseph","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.06.005_bb0650","article-title":"Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life","volume":"2020","author":"Gates","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.molmed.2024.06.005_bb0655","first-page":"868","article-title":"Computerized structured cognitive training in patients affected by early-stage Alzheimer\u2019s disease is feasible and effective: a randomized controlled study","volume":"31","author":"Cavallo","year":"2016","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.molmed.2024.06.005_bb0660","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/HTR.0000000000000203","article-title":"Computerized cognitive rehabilitation of attention and executive function in acquired brain injury: a systematic review","volume":"31","author":"Bogdanova","year":"2016","journal-title":"J. Head Trauma Rehabil."},{"key":"10.1016\/j.molmed.2024.06.005_bb0665","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0970","article-title":"Evaluation of computerized cognitive training and cognitive and daily function in patients living with HIV","volume":"5","author":"Wei","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.molmed.2024.06.005_bb0670","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/23279095.2017.1357037","article-title":"Effect of transcranial direct current stimulation combined with cognitive training on cognitive functioning in older adults with HIV: a pilot study","volume":"26","author":"Fazeli","year":"2019","journal-title":"Appl. Neuropsychol. Adult"},{"key":"10.1016\/j.molmed.2024.06.005_bb0675","first-page":"581","article-title":"Perceived improvement and satisfaction with training after individualized-targeted computerized cognitive training in adults with HIV-associated neurocognitive disorder living in Alabama: a descriptive cross-sectional study","volume":"33","author":"Byun","year":"2022","journal-title":"J. Assoc. Nurses AIDS Care"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424001631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424001631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T18:17:15Z","timestamp":1731521835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424001631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":135,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1471491424001631"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.06.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive impairment in people living with HIV: mechanisms, controversies, and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}